Ribavirin is Absolutely Contraindicated in Pregnancy
Ribavirin is the anti-hepatitis drug that is strictly contraindicated in pregnancy due to its embryocidal and teratogenic effects, classified as FDA Pregnancy Category X. 1
Why Ribavirin is Contraindicated
Ribavirin demonstrates clear teratogenic and embryocidal properties in both animal and human studies. The evidence is unequivocal:
- Category X classification: This is the highest level of contraindication, meaning the risks clearly outweigh any potential benefits 1
- Mandatory contraception requirements: Both women AND men taking ribavirin must use highly effective contraception 1
- Extended washout period: Conception must be deferred for at least 6 months after the last ribavirin dose for both partners 1
The Ribavirin Pregnancy Registry was specifically established to monitor inadvertent exposures, underscoring the serious concern about this medication in pregnancy 2.
Context: Other Anti-Hepatitis Medications in Pregnancy
To clarify the landscape of hepatitis medications during pregnancy:
Hepatitis C Medications:
- Direct-acting antivirals (DAAs): Not approved for pregnancy use, but NOT contraindicated 3. The 2021 SMFM guidelines recommend DAAs only be initiated in clinical trials during pregnancy, with shared decision-making if pregnancy occurs during treatment 3
- Ribavirin-free DAA regimens: Show promise with no adverse fetal effects in animal studies, but lack adequate human data 3
Hepatitis B Medications:
- Tenofovir (TDF): Pregnancy Category B - preferred choice during pregnancy 4, 5
- Telbivudine: Category B - acceptable option 5, 6
- Lamivudine: Category C - less preferred but used 5
Critical Clinical Pitfall
The most important distinction: Ribavirin is the ONLY anti-hepatitis medication that is absolutely contraindicated (Category X). All other medications fall into Category B or C, meaning they may be used when benefits outweigh risks, but ribavirin must never be used during pregnancy or within 6 months of conception attempts by either partner.